Fig. 5From: Xpert MTB/RIF assay for the diagnosis of rifampicin resistance in different regions: a meta-analysisThe SROC plot of Xpert MTB/RIF sensitivity and specificity for rifampicin resistance detection. a High income countries, b Middle/low income countries, c High TB burden countries, d Middle/low TB prevalence countries. The points represent the sensitivity and specificity of one study; the summary point represents the summary sensitivity and specificityBack to article page